Bone Generation by using Three-Dimensional Geometrical Structural Controlled Cell Scaffold and Osteogenetic Growth Stimulated Factor Controlled Delivery System
使用三维几何结构控制细胞支架和成骨生长刺激因子控制输送系统进行骨生成
基本信息
- 批准号:17500322
- 负责人:
- 金额:$ 2.11万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for Scientific Research (C)
- 财政年份:2005
- 资助国家:日本
- 起止时间:2005 至 2006
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Apatite cement and collagen were combined by a mechanochemical method to create a new self-setting apatite/collagen composite cement, and menatetrenone (VK2) was loaded into a drug delivery system to test biocompatibility in rats. The in-vivo cement density microradiograms (CMM) results of the apatite/collagen composite cements suggested that the biodegradation rate was dependent on the cement quality and nano-geometrical structure. The CMM result of VK2 loaded apatite/collagen cements suggested that the biodegradation rates of the cements were significantly dependent on their formulation. The CMM of ground apatite/collagen cement increased until 7 days and then decreased, and bone-like cells penetrated deeply in the center.The therapeutic efficacy of a new calcium phosphate (CaP)-based formulation in improving the bone mineral deficiency in ovariectomized (OVX) rats was investigated. The ions release experiments for CaP preparations (G2:0.46%Mg, 5.78%Zn, and 2.5%F; G3:3.1%Mg,0.03%Zn a … More nd 3.01%F ; G4:1.25%Mg,1.77%Zn,1.35%F) and of a Zn-TCP (G1:6.17%Zn) powders, the initial Mg and Zn ion release rates of MZF-CaPs were performed in acetate buffer at pH 4.5, 37℃. Suspensions consisting of CaP preparations (G2,G3,G4) and of a Zn-TCP (G1) powders were injected in the right thighs of OVX rats in all groups except for GN and GC, once a week for 4 weeks. GN and GC rats were injected with saline solutions. Plasma was analyzed for Zn land alkaline phosphates levels. The bone mineral density (BMD) was measured using DEXA and the bone (femur) strength determined using three-point-bending analysis. G1 and G2 groups showed high plasma Zn levels. The area under the curve of plasma Zn was significantly greater in the G1, G2, and GN groups than in the G3, G4, and GC groups (p<0.05). The BMD and bone mechanical strength of the right femur were significantly higher in the G1, G2, G3 and G4 groups than GC group on day 28. The right femur had significantly greater BMD and bone mechanical strength than the left femur in G1, G2, G3 and G4 groups. Results indicate that the new injectable CaP formulations are effective in improving bone properties of OVX rats and may be useful in osteoporosis therapy. Less
采用机械化学方法将磷灰石骨水泥与胶原蛋白结合,制备出新型自凝磷灰石/胶原复合骨水泥,并将四烯甲萘醌(VK2)负载到药物递送系统中,测试大鼠的生物相容性。磷灰石/胶原复合水泥的体内水泥密度显微放射图(CMM)结果表明,生物降解率取决于水泥质量和纳米几何结构。装载 VK2 的磷灰石/胶原骨水泥的 CMM 结果表明,水泥的生物降解率很大程度上取决于其配方。研磨磷灰石/胶原骨水泥的 CMM 一直增加到 7 天,然后下降,骨样细胞深入中心。 研究了一种新的磷酸钙 (CaP) 配方在改善卵巢切除 (OVX) 大鼠骨矿物质缺乏方面的治疗效果。 CaP制剂(G2:0.46%Mg,5.78%Zn和2.5%F; G3:3.1%Mg,0.03%Zn a … More nd 3.01%F; G4:1.25%Mg,1.77%Zn,1.35%F)和Zn-TCP(G1:6.17%Zn)粉末的离子释放实验,初始Mg和锌离子释放率 MZF-CaPs 在 pH 4.5、37℃ 的醋酸盐缓冲液中进行。将由CaP制剂(G2、G3、G4)和Zn-TCP(G1)粉末组成的悬浮液注射到除GN和GC之外的所有组的OVX大鼠的右大腿中,每周一次,持续4周。 GN和GC大鼠注射盐水溶液。分析血浆中的锌和碱性磷酸盐水平。使用 DEXA 测量骨矿物质密度 (BMD),并使用三点弯曲分析确定骨(股骨)强度。 G1 和 G2 组显示出高血浆锌水平。 G1、G2和GN组的血浆Zn曲线下面积显着大于G3、G4和GC组(p<0.05)。第28天,G1、G2、G3和G4组的右侧股骨BMD和骨机械强度显着高于GC组。G1、G2、G3和G4组右侧股骨的BMD和骨机械强度显着大于左侧股骨。结果表明,新的注射 CaP 制剂可有效改善 OVX 大鼠的骨特性,并可能用于骨质疏松症的治疗。较少的
项目成果
期刊论文数量(19)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Evaluation of the microcrystallinity of a drug substance, indomethacin, in a pharmaceutical model tablet by chemometric FT-Raman spectroscopy
- DOI:10.1007/s11095-005-5281-9
- 发表时间:2005-08-01
- 期刊:
- 影响因子:3.7
- 作者:Okumura, T;Otsuka, M
- 通讯作者:Otsuka, M
Therapeutic Effect of Selected Biomaterials (Mg/Z/F-CaPs, Administrated by Injection) on Bone Properties of Ovariectomized Rats
精选生物材料(Mg/Z/F-CaPs,注射给药)对卵巢切除大鼠骨特性的治疗作用
- DOI:
- 发表时间:2006
- 期刊:
- 影响因子:0
- 作者:M.Otsuka;A.Oshinbe;A.Ito;K.Otsuka;et al.
- 通讯作者:et al.
Comparative evaluation of bioactivity change of crystalline trypsin during compression by Chemoinformaties and 2-D Fourier-transform Infrared,
通过化学信息学和二维傅立叶变换红外对压缩过程中结晶胰蛋白酶的生物活性变化进行比较评估,
- DOI:
- 发表时间:2006
- 期刊:
- 影响因子:0
- 作者:M.Otsuka;Y.Fukui;K.Otsuka;Y.Ozaki
- 通讯作者:Y.Ozaki
Zinc-containing tricalcium phosphate and related materials for promoting bone formation
- DOI:10.1016/j.cap.2004.10.006
- 发表时间:2005-07
- 期刊:
- 影响因子:2.4
- 作者:A. Ito;M. Otsuka;H. Kawamura;M. Ikeuchi;H. Ohgushi;Y. Sogo;N. Ichinose
- 通讯作者:A. Ito;M. Otsuka;H. Kawamura;M. Ikeuchi;H. Ohgushi;Y. Sogo;N. Ichinose
Two-dimensional correlation spectroscopy as a tool for analyzing vibrational images
- DOI:10.1016/j.vibspec.2004.09.005
- 发表时间:2005-03
- 期刊:
- 影响因子:2.5
- 作者:S. Šašić;Mitsuhiko Morimoto;M. Otsuka;Y. Ozaki
- 通讯作者:S. Šašić;Mitsuhiko Morimoto;M. Otsuka;Y. Ozaki
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
OTSUKA Makoto其他文献
OTSUKA Makoto的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('OTSUKA Makoto', 18)}}的其他基金
Nondestructive bioactivity evaluation of molecular orientated hybrid bone cell scaffold by vibration spectroscopy
振动光谱法无损评价分子定向混合骨细胞支架的生物活性
- 批准号:
15K07902 - 财政年份:2015
- 资助金额:
$ 2.11万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Biosignal responsive drug delivery system by using bioactive polymer/ceramic composite bone cement
采用生物活性聚合物/陶瓷复合骨水泥的生物信号响应药物递送系统
- 批准号:
10680809 - 财政年份:1998
- 资助金额:
$ 2.11万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
DEVELOPMENT OF THE EARLY INDICATOR FOR LATE RADIATION DAMAGE
晚期辐射损伤早期指标的开发
- 批准号:
10670858 - 财政年份:1998
- 资助金额:
$ 2.11万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
DEVELOPMENT OF THE EARLY INDICATOR FOR LATE RADIATION DAMAGE OF KIDNEY
肾脏晚期辐射损伤早期指标的发展
- 批准号:
08671039 - 财政年份:1996
- 资助金额:
$ 2.11万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Endogenous signal-responsive drug release from bioactive bone cement
生物活性骨水泥的内源信号响应药物释放
- 批准号:
08680946 - 财政年份:1996
- 资助金额:
$ 2.11万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
相似海外基金
SpyTCR-RBNP - Engineering a highly targeted and biocompatible drug delivery system for solid cancer treatment
SpyTCR-RBNP - 设计用于实体癌症治疗的高度针对性和生物相容性的药物输送系统
- 批准号:
10095606 - 财政年份:2024
- 资助金额:
$ 2.11万 - 项目类别:
Collaborative R&D
骨軟部肉腫に対するカーボン製drug delivery systemの開発
骨软组织肉瘤碳药物递送系统的开发
- 批准号:
24K12414 - 财政年份:2024
- 资助金额:
$ 2.11万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Drug delivery system of osteoclast differentiation inhibitor with carbonate apatite
碳酸磷灰石破骨细胞分化抑制剂的给药系统
- 批准号:
23K16044 - 财政年份:2023
- 资助金额:
$ 2.11万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Smart Nano-carrier for drug delivery system encapsulating peptide drug with high-efficiency
高效包裹肽类药物的药物递送系统智能纳米载体
- 批准号:
23K13803 - 财政年份:2023
- 资助金额:
$ 2.11万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Development of Non-contact Nucleic Acid Drug Delivery System to Whole Body Skin - Challenge to SF Culture Tank -
开发全身皮肤非接触式核酸给药系统 - 挑战SF培养罐 -
- 批准号:
23K18592 - 财政年份:2023
- 资助金额:
$ 2.11万 - 项目类别:
Grant-in-Aid for Challenging Research (Exploratory)
Pioneering research on development of "Drug Delivery System" for deworming gastrointestinal-infected Anisakis
开创性研究开发“药物输送系统”以驱除胃肠道感染的异尖线虫
- 批准号:
23K17446 - 财政年份:2023
- 资助金额:
$ 2.11万 - 项目类别:
Grant-in-Aid for Challenging Research (Pioneering)
Development of an innovative drug delivery system for cancer therapy using platelets as vectors
使用血小板作为载体开发用于癌症治疗的创新药物输送系统
- 批准号:
23H02769 - 财政年份:2023
- 资助金额:
$ 2.11万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Development of Drug Delivery System for RI Drugs Using Chromophore - Assisted Light Inactivation and Computational Science
利用发色团开发 RI 药物的给药系统 - 辅助光灭活和计算科学
- 批准号:
22KJ0538 - 财政年份:2023
- 资助金额:
$ 2.11万 - 项目类别:
Grant-in-Aid for JSPS Fellows
Topical Drug Delivery System as an Anti-Inflammatory and Pro-Angiogenic Therapy for Diabetic Wound Healing
局部给药系统作为糖尿病伤口愈合的抗炎和促血管生成疗法
- 批准号:
10696266 - 财政年份:2023
- 资助金额:
$ 2.11万 - 项目类别:
Targeted drug delivery system to overcome blood-brain barrier and therapeutic resistance to current standard of care in Glioblastoma
靶向药物输送系统可克服血脑屏障和对胶质母细胞瘤现行护理标准的治疗耐药性
- 批准号:
10659749 - 财政年份:2023
- 资助金额:
$ 2.11万 - 项目类别:














{{item.name}}会员




